Zdrowie i gospodarka · 15/03/2019
FDA Releases Final Guidance for Nonclinical Development of Pharmaceuticals for Severely Debilitating or Life-Threatening Hematologic Disorders
The FDA has released a final guidance for the nonclinical development of pharmaceuticals for treating patients with severely debilitating or life-threatening hematologic disorders, aiming to balance patient safety with reduced animal use and streamlined development processes.
Source: Federal Register — Food and Drug AdministrationOpen original release →